Dr. David Michael Enscoe, MD

Dr. Enscoe practices at Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York.

Dr. Enscoe's NPI, 1831274356, was assigned on October 25, 2006. Dr. Enscoe graduated from University Of Florida College Of Medicine in 2006. Dr. Enscoe holds Illinois license 036145666.

Dr. Enscoe's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD, at 1000 South Ave, Rochester, NY 14620.

Dr. Enscoe's primary practice is Smh Infusion Center at Highland Hos - Outpatient Oncology at Hh - HOPD in Rochester, New York. Dr. Enscoe is also affiliated with Highland Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Enscoe to 6 more hospitals, 13 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Enscoe practices, 9 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Enscoe's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Enscoe is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Enscoe's licenses on file in 7 states: Illinois, Iowa, Florida, Georgia, South Carolina, Massachusetts and North Carolina.

CMS data shows 157 Medicare services from Dr. Enscoe across 8 procedure codes in 2024, for 281 Medicare patients. Medicare paid $17,971 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Dr. Enscoe in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Enscoe's median patient age at 51, with 71% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Enscoe for performance year 2024, reported as part of a group. Dr. Enscoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Dr. Enscoe from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $185.

Dr. Enscoe graduated from University Of Florida College Of Medicine in 2006.

Dr. Enscoe is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.